最近の論文

印刷

  • HOME
  • 最近の論文

最近の論文

2018年 | 2017年 | 2016年 | 2015年 | 2014年 | 2013年

Yamamoto, T., Sakamoto, C., Tachiwana, H., Kumabe, M., Matsui, T., Yamashita, T., Shinagawa, M., Ochiai, K., Saitoh, N. and Nakao, M.
Endocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNA.
Sci. Rep., 8, 15202 (2018)
Fujiwara, C., Muramatsu, Y., Nishii, M., Tokunaka, K., Tahara, H., ueno, M., Yamori, T., Sugimoto, Y. and Seimiya, H.
Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells.
Sci. Rep., in press (2018)
Ma, Y., Tsushima, Y., Sakuma, M., Sasaki, S., Iida, K., Okabe, S., Seimiya, H., Hirokawa, T. and Nagasawa, K.
Development of G-quadruplex ligands for selective induction of a parallel-type topology.
Org. Biomol. Chem., in press (2018)
Mizutani, A., Yashiroda, Y., Muramatsu, Y., Yoshida, H., Chikada, T., Tsumura, T., Okue, M., Shirai, F., Fukami, T., Yoshida, M. and Seimiya, H.
RK-287107, a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model.
Cancer Sci., in press (2018)
Ichikawa, Y., Saitoh, N. and Kaufman, P. D.
An asymmetric centromeric nucleosome.
Elife, 7, e37911 (2018)
Kato, Y., Kunimasa, K., Sugimoto, Y. and Tomida, A.
BCR-ABL tyrosine kinase inhibition induces metabolic vulnerability by preventing the integrated stress response in K562 cells.
Biochem. Biophys. Res. Commun., in press (2018)
Ukaji, T., Takemoto, A., Katayama, R., Takeuchi, K. and Fujita, N.
A safety study of newly generated anti-podoplanin-neutralizing antibody in cynomolgus monkey (Macaca fascicularis).
Oncotarget, 9, 33322-33336 (2018)
Nitta, N., Sugimura, T., Isozaki, A., Mikami, H., Hiraki, K., Sakuma, S., Iino, T., Arai, F., Endo, T., Fujiwaki, Y., Fukuzawa, H., Hase, M., Hayakawa, T., Hiramatsu, K., Hoshino, Y., Inaba, M., Ito, T., Karakawa, H., Kasai, Y., Koizumi, K., Lee, S., Lei, C., Li, M., Maeno, T., Matsusaka, S., Murakami, D., Nakagawa, A., Oguchi, Y., Oikawa, M., Ota, T., Shiba, K., Shintaku, H., Shirasaki, Y., Suga, K., Suzuki, Y., Suzuki, N., Tanaka, Y., Tezuka, H., Toyokawa, C., Yalikun, Y., Yamada, M., Yamagishi, M., Yamano, T., Yasumoto, A., Yatomi, Y., Yazawa, M., Di Carlo, D., Hosokawa, Y., Uemura, S., Ozeki, Y. and Goda, K.
Intelligent Image-Activated Cell Sorting.
Cell, in press (2018)
Osumi, H., Shinozaki, E., Mashima, T., Wakatsuki, T., Suenaga, M., Ichimura, T., Ogura, M., Ota, Y., Nakayama, I., Takahari, D., Chin, K., Miki, Y. and Yamaguchi, K.
Phase II Trial of Biweekly Cetuximab and Irinotecan as Third-Line Therapy for Pretreated KRAS Exon 2 Wild-Type Colorectal Cancer.
Cancer Sci., in press (2018)
Koido, M., Tani, Y., Tsukahara, S., Okamoto, Y. and Tomida, A.
InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatmen.
Oncotarget, 9, 29097-29111 (2018)

このページのTOPへ